Search clinical trials for: HIV Vaccine

Total 21998 results

Merck Sharp & Dohme LLC

Completed

A Study of Safety, Tolerability, and Immunogenicity of the MRKAd5 Gag/Pol/Nef Vaccine in Healthy Adults (V520-016)

HIV Infections | HIV-1
InnaVirVax

Completed

Phase I/IIa Dose-escalation Clinical Study of VAC-3S

HIV-1 Infection

France
Bavarian Nordic

Completed

Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection

HIV Infections

Germany
Hopital Foch
Saint-Louis Hospital, Paris, France; INSERM UMR912-SE4S, Marseille, France

Completed

Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital (RAVVIH)

HIV

France
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation

Completed

Immunogenicity and Safety of Trivalent Influenza Vaccine in Pregnant and Nonpregnant HIV Uninfected Women

Influenza

South Africa
University of Witwatersrand, South Africa

Completed

Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women

Influenza

South Africa
University of Virginia
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults

Hepatitis C | Human Immunodeficiency Virus

United States, Puerto Rico
Pfizer

Completed

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine

HIV Infections | Pneumococcal Infections

South Africa, Romania
Uniformed Services University of the Health Sciences
National Institute of Allergy and Infectious Diseases (NIAID); US Military... and other collaborators

Completed

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

HIV Infections | Streptococcus Pneumoniae

United States
National Institute of Allergy and Infectious Diseases...

Completed

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Candidiasis | Bacterial Vaginosis | Trichomoniasis

United States, Kenya
Novartis
Novartis Vaccines

Completed

Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Influenza

Czech Republic, Philippines, South Africa, Thailand
Boehringer Ingelheim

Completed

Pharmacokinetic Study in Healthy Adult Volunteers to Assess the Interactions Between Steady-State Tipranavir and Atazanavir in the Presence of Ritonavir

Healthy
Boehringer Ingelheim

Terminated

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

Healthy
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

Measles

Zambia
Novartis Vaccines

Completed

Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings

Bacterial Infections | Streptococcal Infections | Gram-Positive Bacterial Infections

South Africa, Malawi
Robert L. Murphy
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (EraMune02)

HIV Infection

United States
University of Sao Paulo

Completed

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil (HPV)

Infection

Brazil
The HIV Netherlands Australia Thailand Research...
Pediatric infectious diseases section, King Chulalongkorn Memorial hospital...

Completed

Pneumococcal Conjugate Vaccine (PCV) in HIV- Infected Children

HIV

Thailand
Boehringer Ingelheim

Completed

Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy Volunteers

Healthy
University of Oxford
University of Washington; KEMRI-Wellcome Trust Collaborative Research Program; International AIDS Vaccine Initiative and other collaborators

Completed

Targeted Screening of At-Risk Adults for Acute HIV-1 Infection (AHI)

HIV

Kenya
University of Southern California
National Cancer Institute (NCI)

Terminated

Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
PX'Therapeutics
European Commission

Completed

Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine

- HIV

United Kingdom
PX'Therapeutics
European Commission

Completed

EuroNeut41: Safety & Immunogenicity of Immunisations With HIV Vaccine

HIV

United Kingdom
Rockefeller University

Completed

DCVax Plus Poly ICLC in Healthy Volunteers

HIV Infection | Healthy Volunteers | HIV-1 Infection

United States
University of Oxford

Completed

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults (HIV-CORE 002)

HIV-1 Infections

United Kingdom
University of Siena
Ministry of Education, Universities and Research, Italy

Completed

Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV Adults (PCV13HIV2011)

HIV Infection | Pneumococcal Infections

Italy
University of Miami
National Institute of Allergy and Infectious Diseases (NIAID); Vaccine and...

Completed

Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study

HIV

United States
US Department of Veterans Affairs
Albert Einstein College of Medicine; Montefiore Medical Center

Completed

Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects

HIV Infections

United States
Emory University
Makerere University

Completed

Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda

Acquired Immunodeficiency Syndrome | HIV | Influenza

Uganda
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma

Recurrent Melanoma | Stage IV Melanoma

United States
Centers for Disease Control and Prevention

Withdrawn

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Tetanus | HIV | Malaria | Influenza, Human | Polio

Kenya
National Institute of Allergy and Infectious Diseases...
Center for HIV/AIDS Vaccine Immunology

Completed

Examining Factors That May Influence Resistance to HIV-1 Infection

HIV Infections

Uganda, United Kingdom
New York Blood Center
Rutgers University; The New York Academy of Medicine

Completed

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

HIV Infections | Hepatitis B

United States
Gitte Kronborg
Rigshospitalet, Denmark; Hvidovre University Hospital; Statens Serum Institut; Ministry...

Completed

Immunization With HIV-1 Peptides in Adjuvant for Treatment of Patients With Chronic HIV-infection (HIV-VAC)

HIV INFECTIONS

Denmark
Aeras
Statens Serum Institut

Completed

A Phase I Study to Evaluate Safety and Immunogenicity of AERAS 404 Administered in Adults

Tuberculosis

Finland
Janssen R&D Ireland

Completed

A Study to Explore Pharmacokinetic Interaction Between Rilpivirine and Metformin in Healthy Participants

Healthy Participants

United States
Imperial College London
CUT'HIVAC Cutaneous HIV Vaccination

Unknown

Immunogenicity of Three HIV GTU® MultiHIV DNA Immunisations Administered Via Intramuscular, Intradermal and Transcutaneous Routes (CUT*HIVAC001)

HIV

United Kingdom
Hospital Clinic of Barcelona

Completed

Dendritic Cell Vaccine in HIV-1 Infection

HIV Infections

Spain
Aeras
Statens Serum Institut

Completed

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

Tuberculosis

Sweden
CIHR Canadian HIV Trials Network
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Early Versus Delayed Pneumococcal Vaccination in HIV

Pneumococcal Infections

Canada
Sanofi Pasteur, a Sanofi Company

Terminated

Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia Naive

HIV Infections | Smallpox

United States
Roswell Park Cancer Institute

Completed

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Unknown

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)

United States
Medical Research Council

Unknown

Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom
Milton S. Hershey Medical Center

Unknown

Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or Neuroblastoma

Sarcoma | Neuroblastoma

United States
University of Witwatersrand, South Africa
Bill and Melinda Gates Foundation

Completed

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

Influenza | Human Immunodeficiency Virus

South Africa
Instituto Nacional de Saúde, Mozambique
European and Developing Countries Clinical Trials Partnership (EDCTP); Swedish...

Completed

Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine

HIV Infections

Mozambique
National Institute of Allergy and Infectious Diseases...

Completed

Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

HIV Infections

United States, Denmark
National Institute of Allergy and Infectious Diseases...

Completed

Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised

HIV Infections

United States, Canada

3

Subscribe